Speaker Name: Dr. Juris Meier, Chief Physician of Medicine, HOD-Diabetology & GI Endocrinology, Augusta-Kranken-Anstalt, Bochum Center, North Rhine-Westphalia, Germany.

Explore this session to:

• Understand how physiologic insulin profiles guide selection of basal, prandial, and intensive insulin regimens.
• Review why basal insulin remains the preferred strategy for initiating insulin therapy in most patients with T2DM.
• Compare newer basal insulin analogs and once-weekly insulins for glycemic control, hypoglycemia risk, and treatment satisfaction.
• Evaluate the role of rapid and ultra-rapid mealtime insulins in improving postprandial glucose control.
• Recognize practical factors influencing insulin absorption, adherence, and day-to-day glycemic variability.